VALOR MANAGEMENT LLC
Q4 2024 Form 13-F
CHICAGO, ILLINOIS
CIK 0001846237
· CRD 160014
· SEC-registered investment adviser
$249.2M Reported Value Total
VALOR EQUITY PARTNERS reports 48 total accounts under management (AUM). There are 47 discretionary accounts valued at $16,483,237,796, and 1 non-discretionary accounts valued at $504,585,716.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
69 funds
· $63.7B gross asset value
Private Equity Fund: $62.9B · Venture Capital Fund: $786.9M
Source: Form ADV filed 2026-04-29
Reported value
$249.2M
Quarter over quarter
-14.1%
Holdings
4
Top-10 concentration
100.0%
Key People
Form ADV owners & control persons
Antonio Jose Gracias
SOLE SHAREHOLDER; SOLE DIRECTOR
Anne Marie Dean
CHIEF FINANCIAL OFFICER
Cassie Hyun Chung Peterson
CHIEF COMPLIANCE OFFICER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q4 2024 13F record
Q4 2024 13F filing summary
| Period of report | December 31, 2024 |
|---|---|
| Filed | February 14, 2025 |
| Form | 13F-HR |
| Reported value | $249.2M |
| Positions | 4 |
| Change in reported value | -47.5% |
| New positions | 1 |
| Exited positions | 1 |
| Position turnover | 40.0% |
| Top-10 concentration | 100.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 16, 2026
|
5 | $68.4B |
|
Q2 2026 13F
Filed Aug 14, 2026
|
5 | $86.2B |
|
Q1 2026 13F
Filed May 13, 2026
|
5 | $180.9M |
|
Q4 2025 13F
Filed Feb 13, 2026
|
3 | $55.1M |
|
Q3 2025 13F
Filed Nov 14, 2025
|
4 | $67.3M |
|
Q2 2025 13F
Filed Aug 14, 2025
|
4 | $238.1M |
|
Q1 2025 13F
Filed May 15, 2025
|
4 | $240.6M |
|
Q4 2024 13F
Filed Feb 14, 2025
|
4 | $249.2M |
|
Q3 2024 13F
Filed Nov 12, 2024
|
4 | $474.6M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
6 | $454.7M |
|
Q1 2024 13F
Filed May 15, 2024
|
6 | $479.6M |
|
Q4 2023 13F
Filed Feb 14, 2024
|
3 | $364.0M |
|
Q3 2023 13F
Filed Nov 13, 2023
|
4 | $371.5M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
5 | $401.6M |
|
Q1 2023 13F
Filed May 15, 2023
|
4 | $379.7M |
|
Q4 2022 13F
Filed Feb 14, 2023
|
4 | $634.0M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
3 | $520.5M |
|
Q2 2022 13F
Filed Aug 11, 2022
|
3 | $566.7M |
|
Q1 2022 13F
Filed May 13, 2022
|
4 | $655.5M |
|
Q4 2021 13F
Filed Feb 9, 2022
|
4 | $627.7M |
Top 4 holdings · Q4 2024
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | HRMY Harmony Biosciences Holdings Inc | $227.7M | 91.4% |
| 2 | BWAY BrainsWay Ltd. | $19.8M | 7.96% |
| 3 | SONDQ Sonder Holdings Inc | $1.5M | 0.61% |
| 4 | BIOA BioAge Labs, Inc. | $75.9K | 0.03% |
Values as reported on the Q4 2024 Form 13F. Every position is in the holdings table below.